Palomero, J., Panisello, C., Lozano-Rabella, M., Tirtakasuma, R., Díaz-Gómez, J., Grases, D., . . . Gros, A. (2022). Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.
Chicago Style CitationPalomero, Jara, et al. Biomarkers of Tumor-reactive CD4+ and CD8+ TILs Associate With Improved Prognosis in Endometrial Cancer. 2022.
MLA CitationPalomero, Jara, et al. Biomarkers of Tumor-reactive CD4+ and CD8+ TILs Associate With Improved Prognosis in Endometrial Cancer. 2022.
Warning: These citations may not always be 100% accurate.